Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-17

Clinical Trial Update: Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases [EARLY_Phase 1]

View source ↗

Summary

A phase 1 trial is evaluating arginine in combination with whole-brain radiation therapy for brain metastases and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-Arginine (L-Arginine)

Snippet

Sponsor: Emory University | Conditions: Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm | EARLY_Phase 1 | Status: RECRUITING